Literature DB >> 9434876

Polymorphisms in the p53 gene in thyroid tumours and blood samples of children from areas in Belarus.

S Hillebrandt1, C Streffer, E P Demidchik, J Biko, C Reiners.   

Abstract

We present changes in the p53 gene in a group of 70 thyroid tumours and 40 blood samples obtained from children from Belarus. Three thyroid tumours show a polymorphism in exon 6 (codon 213) and 5 tumours show a polymorphism in intron 6, 37 bp upstream to the 5'-end of exon 7. Only one patient has a mutation in exon 7 (codon 258) resulting in an amino acid substitution in the protein p53. The distribution of polymorphisms in the 40 blood samples was as follows: three patients had a polymorphism in exon 6 and two persons had a polymorphism in intron 6. One polymorphism in intron 6 was also found in the group of 30 healthy children from Belarus. The fact that the differences in the sequence in p53 found in the tumours was also seen in the blood of these patients demonstrates that they are polymorphisms not induced by radiation exposure. It is difficult to conclude, if the polymorphisms found by us could be associated with the predisposition to radiation-induced cancer.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9434876     DOI: 10.1016/s0027-5107(97)00169-3

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  10 in total

1.  Mutation and homozygous deletion analyses of genes that control the G1/S transition of the cell cycle in skin melanoma: p53, p21, p16 and p15.

Authors:  José Luis Soto Martínez; Carmen M Cabrera Morales; Sabio Serrano Ortega; Miguel Angel López-Nevot
Journal:  Clin Transl Oncol       Date:  2005-05       Impact factor: 3.405

2.  Duplex Detection of TP53 Arg72Pro and 16 bp Del/Ins Polymorphisms by a Simple Optimized PCR-RFLP Method.

Authors:  B Lajin; A Alachkar; Sakur A Alhaj
Journal:  N Am J Med Sci       Date:  2012-05

3.  Mutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2B.

Authors:  José Luis Soto; Carmen M Cabrera; Salvio Serrano; Miguel Angel López-Nevot
Journal:  BMC Cancer       Date:  2005-04-08       Impact factor: 4.430

4.  Gene rearrangement and Chernobyl related thyroid cancers.

Authors:  M Santoro; G A Thomas; G Vecchio; G H Williams; A Fusco; G Chiappetta; V Pozcharskaya; T I Bogdanova; E P Demidchik; E D Cherstvoy; L Voscoboinik; N D Tronko; A Carss; H Bunnell; M Tonnachera; J Parma; J E Dumont; G Keller; H Höfler; E D Williams
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

5.  Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations.

Authors:  S Wang-Gohrke; W Weikel; H Risch; D Vesprini; J Abrahamson; C Lerman; A Godwin; R Moslehi; O Olipade; J S Brunet; E Stickeler; D G Kieback; R Kreienberg; B Weber; S A Narod; I B Runnebaum
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

Review 6.  Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment.

Authors:  Roman Hrstka; Philip J Coates; Borivoj Vojtesek
Journal:  J Cell Mol Med       Date:  2009-03       Impact factor: 5.310

7.  Intronic TP53 Germline Sequence Variants Modify the Risk in German Breast/Ovarian Cancer Families.

Authors:  Xuan Liu; Hans-Peter Sinn; Hans Ulrich Ulmer; Rodney J Scott; Ute Hamann
Journal:  Hered Cancer Clin Pract       Date:  2004-07-15       Impact factor: 2.857

8.  Association of PIN3 16-bp duplication polymorphism of TP53 with breast cancer risk in Mali and a meta-analysis.

Authors:  Brehima Diakite; Yaya Kassogue; Guimogo Dolo; Oumar Kassogue; Mamadou Lassine Keita; Brian Joyce; Erin Neuschler; Jun Wang; Jonah Musa; Cheick Bougari Traore; Bakarou Kamate; Etienne Dembele; Sellama Nadifi; Mercy Isichei; Jane L Holl; Robert Murphy; Seydou Doumbia; Lifang Hou; Mamoudou Maiga
Journal:  BMC Med Genet       Date:  2020-07-03       Impact factor: 2.103

Review 9.  Role of p53 in Regulating Radiation Responses.

Authors:  Ryuji Okazaki
Journal:  Life (Basel)       Date:  2022-07-21

10.  Intronic SNPs of TP53 gene in chronic myeloid leukemia: Impact on drug response.

Authors:  K Sailaja; V R Rao; Satish Yadav; R Rajasekhar Reddy; D Surekha; D Nageswara Rao; D Raghunadharao; S Vishnupriya
Journal:  J Nat Sci Biol Med       Date:  2012-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.